Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T) (vol 18, pg 575, 2007)

被引：0
|
作者：
Usami, O.
Ashino, Y.
Komaki, Y.
机构：
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 2007年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [1] Efavirenz-induced neurological symptoms in rare homozygote CYP2B6*2/*2 (C64T)
    Usami, Osamu
    Ashino, Yugo
    Komaki, Yuichi
    Tomaki, Masafurni
    Irokawa, Toshiya
    Tamada, Tsutornu
    Hayashida, Tsunefusa
    Teruya, Katsuji
    Hattori, Toshio
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (08) : 575 - 576
  • [2] ASSOCIATION OF THE CYP2B6*6 ALLELE WITH EFAVIRENZ-INDUCED QT INTERVAL CHANGES AT STEADY STATE IN HEALTHY SUBJECTS
    Abdelhady, A. M.
    Thong, N.
    Kreutz, Y.
    Tisdale, J. E.
    Desta, Z.
    Overholser, B. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S22 - S23
  • [3] The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans (vol 41, pg 575, 2013)
    IIic, K.
    Hawke, R. L.
    Thirumaran, R. K.
    Schuetz, E. G.
    Hull, J. H.
    Kashuba, A. D.
    Stewart, P. W.
    Lindley, C. M.
    Chen, M. L.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) : 1137 - 1137
  • [4] CYP2B6 poor metaboliser alleles involved in efavirenz and nevirapine metabolism: CYP2B6*9 and CYP2B6*18 distribution in HIV-exposed subjects from Dschang, Western Cameroon
    Paganotti, Giacomo Maria
    Russo, Gianluca
    Sobze, Martin Sanou
    Mayaka, George Bouting
    Muthoga, Charles Waithaka
    Tawe, Leabaneng
    Martinelli, Axel
    Romano, Rita
    Vullo, Vincenzo
    INFECTION GENETICS AND EVOLUTION, 2015, 35 : 122 - 126
  • [5] CYP2B6 18492T→C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype*1/*1
    Manosuthi, Weerawat
    Sukasem, Chonlaphat
    Thongyen, Supeda
    Nilkamhang, Samruay
    Manosuthi, Sukanya
    Sungkanuparph, Somnuek
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2268 - 2273
  • [6] Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry (vol 47, pg 1195, 2019)
    Wang, P-F
    Neiner, A.
    Kharasch, E. D.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1231 - 1231
  • [7] Allelic and Genotype Frequencies of CYP2B6*2 (64C > T) and CYP2B6*3 (777C > A) in Three Dominant Ethnicities of the Iranian Population
    Khavandegar, Armin
    Tavakoli-Far, Bahareh
    Ansari, Sarina
    Veis-Karami, Parisa
    Ghasemi, Faezeh
    Sheibaninia, Samira
    Jazayeri, Roshanak
    Houshmand, Massoud
    GENETICS RESEARCH, 2023, 2023
  • [8] CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women
    Roehrich, Carola R.
    Droegemoeller, Britt I.
    Ikediobi, Ogechi
    van der Merwe, Lize
    Grobbelaar, Nelis
    Wright, Galen E. B.
    McGregor, Nathaniel
    Warnich, Louise
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (06) : 529 - 538
  • [9] CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
    Milcah Dhoro
    Simbarashe Zvada
    Bernard Ngara
    Charles Nhachi
    Gerald Kadzirange
    Prosper Chonzi
    Collen Masimirembwa
    BMC Pharmacology and Toxicology, 16
  • [10] CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
    Dhoro, Milcah
    Zvada, Simbarashe
    Ngara, Bernard
    Nhachi, Charles
    Kadzirange, Gerald
    Chonzi, Prosper
    Masimirembwa, Collen
    BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
12345